Yiheng Capital Management, L.P. Allakos Inc. Transaction History
Yiheng Capital Management, L.P.
- $1.8 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding ALLK
# of Institutions
105Shares Held
77.4MCall Options Held
70.7KPut Options Held
2.8K-
Bvf Inc San Francisco, CA16.6MShares$12.6 Million0.62% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$4.67 Million0.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$3.8 Million0.21% of portfolio
-
Black Rock Inc. New York, NY4.72MShares$3.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.79MShares$2.88 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $64.4M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...